Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SPAGO.ST
- Price
- 0.22
- Stock movement up
- +0.02 (9.50%)
- Company name
- Spago Nanomedical AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 76.25M
- Ent value
- 42.29M
- Price/Sales
- 37.66
- Price/Book
- 1.85
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -2.40%
- 1 year return
- -18.28%
- 3 year return
- -58.83%
- 5 year return
- -46.16%
- 10 year return
- -33.79%
Last updated: 2025-04-15
DIVIDENDS
SPAGO.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 37.66 |
| Price to Book | 1.85 |
| EV to Sales | 20.89 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 348.20M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 39.95M |
| Net receivables | 201.00K |
| Total current assets | 46.09M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 691.00K |
| Total assets | 47.10M |
| Accounts payable | 3.04M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 5.58M |
| Total liabilities | 5.98M |
| Shareholder's equity | 41.12M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.22 |
| Daily high | 0.22 |
| Daily low | 0.22 |
| Daily Volume | 1K |
| All-time high | 25.91 |
| 1y analyst estimate | 1.00 |
| Beta | 2.12 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SPAGO.ST | S&P500 | |
| Current price drop from All-time high | -99.15% | -12.04% |
| Highest price drop | -99.34% | -56.47% |
| Date of highest drop | 16 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -60.85% | -11.07% |
| Avg time to new high | 103 days | 12 days |
| Max time to new high | 2494 days | 1805 days |
COMPANY DETAILS
Marketcap
76.25M
Marketcap category
Small-cap
Description
Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer, as well as offers Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under Preclinical development stage. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.
Employees
12
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
LUND, SE / ACCESS Newswire / April 9, 2025 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) This English version of the notice to the Annual General Meeting is for convenience only. The Swedish version p...
April 9, 2025
LUND, SE / ACCESS Newswire / March 20, 2025 /Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that the company's nomination committee proposes a changed board co...
March 20, 2025
LUND, SE / ACCESSWIRE / March 04, 2025 / Spago Nanomedical (STO:SPAGO.ST) (FRA:7UX.F) Spago Nanomedical AB (publ) announced today that the independent Data Monitoring Committee (DMC) recommends a dose...
March 4, 2025
Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) OCTOBER - DECEMBER IN BRIEF Net sales for the quarter amounted to KSEK 617 (KSEK 731) The loss for the quarter amounted to KSEK -7,830 (KSEK -9,417) Operati...
February 6, 2025
LUND, SWEDEN / ACCESSWIRE / January 15, 2025 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that a manuscript on product candidate pegfosimer manganese has b...
January 15, 2025
LUND, SE / ACCESSWIRE / December 18, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) today announced that all patients in the second patient group have been dosed accord...
December 18, 2024
LUND, SWEDEN / ACCESSWIRE / November 6, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Progress for the Tumorad program JULY - SEPTEMBER IN BRIEF Net sales for the quarter amounted to KSEK 485 (KS...
November 6, 2024
LUND, SE / ACCESSWIRE / October 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) In accordance with the instructions to the nomination committee resolved by the Annual General Meeting ("AGM"), a...
October 21, 2024
LUND, SWEDEN / ACCESSWIRE / October 1, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) The Board of Directors of Spago Nanomedical AB (publ) has decided that the company's resources will be focused...
October 1, 2024
LUND, SE / ACCESSWIRE / August 27, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) today announced that the independent Data Monitoring Committee (DMC) recommends to pro...
August 27, 2024
Next page